BridgeMD
Tests treatment safety and results for ACL Injury
Official title The Efficiency and Safety of PRP Treatment After Anterior Cruciate Ligament Reconstruction.
ClinicalTrials.gov ID: NCT06442319
What this study is testing
What is Platelet-rich plasma?
Platelet-rich plasma is an investigational medicine, given as an injectable medicine, being studied as a potential treatment for acl injury.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The anterior cruciate ligament (ACL) is the main stabilizer of the knee joint, as it controls anteroposterior and rotatory knee laxity. The number of ACL injuries has increased in the past three decades because more and more people participate in recreational and competitive sporting activities.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 45
You may be able to join if
- subject is 18-45 years old
- subject has BMI \< 40 kg/m2
- subject had ACL reconstrution
- small asymptomatic meniscal lesions that won't require repair
- subject must be willing to abstain from other intra-articular treatments of the knee for the duration of the study.
You likely can't join if
- subject has a history of metabolic diseases, endocrine disorders, rheumatic and connective tissue diseases, cancer, hormonal contraception, steroid...
- subject had an intraarticular injection into the affected joint
- subject had previous operations (beside ACL reconstruction) or fractures of the affected limb
- subject has a history of nicotine, alcohol, or drug addiction
- subject has a meniscal tear that requires suturing or total meniscectomy seen on MRI
- subject has multi-ligament knee injuries or multi-organ injury
See the full eligibility criteria
- subject is 18-45 years old
- subject has BMI \< 40 kg/m2
- subject had ACL reconstrution
- small asymptomatic meniscal lesions that won't require repair
- subject must be willing to abstain from other intra-articular treatments of the knee for the duration of the study.
- subject is willing to discontinue all analgesics including nonsteroidal anti-inflammatory drugs (NSAIDs), except tramadol and paracetamol, at least one month before the synovial fluid aspiration and through the...
- subject is able to understand and comply with the requirements of the study and voluntarily provides consent
- subject has a history of metabolic diseases, endocrine disorders, rheumatic and connective tissue diseases, cancer, hormonal contraception, steroid therapy, antibiotic therapy
- subject had an intraarticular injection into the affected joint
- subject had previous operations (beside ACL reconstruction) or fractures of the affected limb
- subject has a history of nicotine, alcohol, or drug addiction
- subject has a meniscal tear that requires suturing or total meniscectomy seen on MRI
- subject has multi-ligament knee injuries or multi-organ injury
- subject has significant varus or valgus deformity greater than 10 degrees in either knee, determined by an X-ray
The study team makes the final eligibility decision.
Where it's taking place
- Torun, Poland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 45 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Torun, Poland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.